Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDP vs TMZ in refractory anaplastic astrocytoma with unmethylated MGMT promoter
ChiCTR-IIR-17010500Phase 2Not yet recruiting
- Sponsor
- Shanghai Gamma Knife Hospital
- Start
- Mar 2017
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in anaplastic astrocytoma (AA) comparing Cisplatin + standard treatment with Temozolomide standard treatment (2 arms). Planned start Mar 2017; status: not yet recruiting.
02
Drugs
cisplatintemozolomide
03
Conditions
anaplastic astrocytoma (AA)
Beyond the preview
Go deeper on ChiCTR-IIR-17010500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17010500.